Dr. Betz Holloran in Rome in 2016
Dr. Betz Halloran in Rome in 2016, with collaborators Dr. Ira Longini (L) and Dr. Alex Vespignani (R), to accept the Aspen Institute Italia Award that recognized her research on the impact that Ebola treatment centers had in curbing the epidemic in Liberia. Photo courtesy of Dr. Dennis Chao


Dr. Betz Halloran chair-elect of AAAS Section on Statistics

Hutch News | January 2018
The AAAS Section on Statistics is one of 24 groups that direct the organization’s activities, including planning symposia, electing fellows and educating the general public about science.


To protect, or to enhance? That is the question for Dengue virus antibodies

Science Spotlight | December 2017
In work published in Science, a cross-institute collaboration involving Dr. Betz Halloran from the Vaccine and Infectious Disease Division at Fred Hutch studied the relationship between preexisting Dengue virus antibodies and disease severity in a large pediatric Nicaraguan cohort.

Reconstructing Zika’s travels in the Americas

Science Spotlight | June 2017
In a study published in PNAS, researchers created a data driven stochastic spatial epidemic model to analyze the spread and magnitude of Zika virus infection in the Americas. 


Dr. Betz Halloran collects research award in Rome

Hutch News | October 2016
Dr. Betz Halloran received the Aspen Institute Italia Award for her research on the impact that Ebola treatment centers had in curbing the epidemic in Liberia. She was one of 10 scientists from five organizations who shared the prize for co-authoring the winning analysis, originally published in 2015 in the journal The Lancet Infectious Diseases.

Tracking the rise and fall of Ebola in Sierra Leone

Hutch News | March 2016
A team of biostatisticians including Fred Hutch’s Dr. Betz Halloran published a study showing how the Ebola virus impacted Liberia, and offered insight on interventions that worked to curb the disease's spread.


Ebola lessons applied to vaccine clinical trials

Hutch News | April 2015
In a perspective published in Science, researchers from Fred Hutchinson Cancer Research Center and other institutions drew on lessons learned in the ongoing Ebola epidemic in West Africa to suggest guidelines for conducting vaccine clinical trials during an infectious disease emergency.


Fred Hutchinson Cancer Research Center designated MIDAS Center of Excellence

News Releases | September 2014
Models of Infectious Disease Agency Study (MIDAS) centers are designated to play a role in planning for national emergencies such as a pandemic or an act of bioterrorism. Dr. Betz Halloran heads the new MIDAS center, one of only three such sites across the nation.